Reading through the Hotcopper Forums, -- enables Investors of all sizes, to find an Echo chamber to confirm their investment strategy. as well as be very entertaining -- when there are conflicting views.
I first jumped in to ADO, as a small investor/ gambler several years ago, around six to eight cents.... -- my circumstances altered, and I sold out of ADO around the eighteen cents --lamenting all the while as the share price seemed to be unstoppable, as it soared up over the 30cent mark and beyond.
I re-entered ADO two years ago --around the six cent mark, and have dabbled and added a few at four cents and again at the CR and obtained some Options as well.
ADO has a market cap around 55million -- at a share price of 0.022 means there is roughly 2,500,000,000 (2.5Billion shares) -- This CR with 3.5million dollars to be raised by issuing 175million shares to Sophs - is well with in the boards discretionary power. (175milion is approximately is 7%increase in number of shares).
nearly every Listed Company has a built in resolution, that allows upto 10% issuance of shares --
So the OFFER (over and above the sophs) of 1-10 for existing Share Holders (at the same price as the Sophs) -- to me seems very fair.
an extra 10percent on top of my share number will not greatly affect me.
ADO has been a speculative stock for years -- ADO Share holder -- some have earnt and many have been burnt.
Our battery division could be worth billions -- and our Serum (just with the India testing program ) could be enormous as well.
Imagine if BOTH Divisions hit half their potential at the same time?
May those that are still invested make a Profit sooner then later.
GLALTH.
- Forums
- ASX - By Stock
- ADO
- Ann: AnteoTech $3.5m Placement, launch of $5m Entitlement Offer
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.4¢

Ann: AnteoTech $3.5m Placement, launch of $5m Entitlement Offer, page-119
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.87M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $12.64K | 886.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1057201 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 4211074 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1057201 | 0.014 |
6 | 1159222 | 0.013 |
7 | 2083372 | 0.012 |
7 | 2658674 | 0.011 |
7 | 3309000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 4211074 | 13 |
0.016 | 1427582 | 2 |
0.017 | 218695 | 4 |
0.018 | 1186369 | 5 |
0.019 | 1117333 | 8 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online